• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why VOXX International Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket

    10/11/23 8:24:04 AM ET
    $AGIL
    $ATHX
    $BCEL
    $CASI
    Professional Services
    Consumer Discretionary
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AGIL alert in real time by email

    Gainers

    Tempest Therapeutics, Inc. (NASDAQ:TPST) shares rose 279.8% to $0.9115 in pre-market trading, after the company announced it plans to report new and updated data from the global randomized combination study of TPST-1120 in first-line hepatocellular carcinoma in a premarket press release on Oct. 11.

    Wheeler Real Estate Investment Trust, Inc. (NASDAQ:WHLR) shares gained 211% to $2.77 in pre-market trading after falling 7% on Tuesday.

    Athersys, Inc. (NASDAQ:ATHX) shares rose 20.7% to $0.14 in pre-market trading, after falling 60% on Tuesday. Athersys said it intends to conduct additional data analysis with independent statisticians because the sample size in the Phase 3 MASTERS-2 is insufficiently powered to achieve the primary endpoint.

    Gaucho Group Holdings, Inc. (NASDAQ:VINO) shares climbed 42.7% to $1.27 in pre-market trading, after falling over 12% on Tuesday. Gaucho Group announced its journey towards organic cultivation for select sections of its renowned Pinot Noir and Cabernet Sauvignon vineyards.

    Connexa Sports Technologies Inc. (NASDAQ:CNXA) rose 34.7% to $2.56 in pre-market trading.

    AgileThought, Inc. (NASDAQ:AGIL) rose 27.7% to $0.1890 in pre-market trading. On Oct. 10, 2023, the Bankruptcy Court entered an order approving AgileThought Parties' and stalking horse buyer's entry into agreement.

    Mangoceuticals, Inc. (NASDAQ:MGRX) shares jumped 24.3% to $0.7360 in pre-market trading after gaining 9% on Tuesday.

    Elys Game Technology, Corp. (NASDAQ:ELYS) gained 19.6% to $0.5982 in pre-market trading. Elys Game Technology disclosed the expansion of its footprint in Washington, D.C. with the addition of a third sportsbook location, Grand Central Sportsbook on H Street.

    Atreca, Inc. (NASDAQ:BCEL) shares surged 15.1% to $0.2417 in pre-market trading, after falling around 9% on Tuesday.

    VOXX International Corp (NASDAQ:VOXX) shares rose 11.7% to $8.70 in pre-market trading as the company reported stronger-than-expected sales for its second quarter.

    Losers

    Silk Road Medical, Inc (NASDAQ:SILK) fell 38.5% to $8.61 in pre-market trading after the company announced preliminary third-quarter revenue results below estimates and issued FY23 revenue guidance below estimates.

    SuperCom Ltd. (NASDAQ:SPCB) fell 25.1% to $0.6588 in pre-market trading, after surging 144% on Tuesday. SuperCom Ltd. is an Israel-based provider of digital identity and cybersecurity products and solutions to governments and private and public organizations throughout the world.

    Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) shares fell 18.2% to $17.14 in pre-market trading.

    Mobilicom Limited (NASDAQ:MOB) shares fell 17.1% to $1.70 in pre-market trading, after jumping over 44% on Tuesday. The Bank of New York Mellon reported in a filing late Monday that it increased its stake in the company.

    SMX (Security Matters) Public Limited Company (NASDAQ:SMX) fell 16.7% to $2.39 in pre-market trading. SMX shares jumped 69% on Tuesday after the company announced it secured a majority stake in True Gold Consortium.

    DaVita Inc. (NYSE:DVA) fell 16.5% to $76.23 in pre-market. Rockwell Medical said on Sept. 18, that the company and Davita entered into an amended and restated products purchase agreement.

    E2open Parent Holdings, Inc. (NYSE:ETWO) fell 15.3% to $3.72 in pre-market trading as the company posted downbeat results for its second quarter and named Andrew Appel as interim CEO, effective immediately.

    ParaZero Technologies Ltd. (NASDAQ:PRZO) shares fell 7.4% to $2.25 in pre-market trading after declining 10% on Tuesday. ParaZero Technologies recently announced an Australian regulator approved the first commercial drone flights in populated areas and near people using ParaZero safety systems.

    Hyliion Holdings Corp. (NYSE:HYLN) shares fell 14.2% to $1.02 in pre-market trading after the company announced a strategic review of alternatives for Electric Powertrain Business.

    CASI Pharmaceuticals, Inc. (NASDAQ:CASI) shares fell 11.9% to $2.66 in pre-market trading.

    Now Read This: Fastenal Gears Up For Q3 Print; Here's A Look At Recent Price Target Changes By The Most Accurate Analysts

    Get the next $AGIL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AGIL
    $ATHX
    $BCEL
    $CASI

    CompanyDatePrice TargetRatingAnalyst
    Tempest Therapeutics Inc.
    $TPST
    1/22/2026$11.00Neutral → Buy
    H.C. Wainwright
    Fresenius Medical Care AG
    $FMS
    1/20/2026Buy → Neutral
    Goldman
    Hyliion Holdings Corp.
    $HYLN
    10/21/2025Buy
    Johnson Rice
    Fresenius Medical Care AG
    $FMS
    10/15/2025Neutral → Underperform
    BofA Securities
    Fresenius Medical Care AG
    $FMS
    9/2/2025Neutral → Sell
    UBS
    Tempest Therapeutics Inc.
    $TPST
    4/10/2025Sector Outperform → Sector Perform
    Scotiabank
    Tempest Therapeutics Inc.
    $TPST
    4/10/2025Buy → Neutral
    H.C. Wainwright
    E2open Parent Holdings Inc.
    $ETWO
    12/11/2024$3.50 → $2.90Neutral → Sell
    Goldman
    More analyst ratings

    $AGIL
    $ATHX
    $BCEL
    $CASI
    SEC Filings

    View All

    SEC Form D filed by Tempest Therapeutics Inc.

    D - Tempest Therapeutics, Inc. (0001544227) (Filer)

    4/3/26 2:28:03 PM ET
    $TPST
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form F-3/A filed by SMX (Security Matters) Public Limited Company

    F-3/A - SMX (Security Matters) Public Ltd Co (0001940674) (Filer)

    4/2/26 4:10:41 PM ET
    $SMX
    Industrial Machinery/Components
    Technology

    SEC Form EFFECT filed by SMX (Security Matters) Public Limited Company

    EFFECT - SMX (Security Matters) Public Ltd Co (0001940674) (Filer)

    4/2/26 12:15:22 AM ET
    $SMX
    Industrial Machinery/Components
    Technology

    $AGIL
    $ATHX
    $BCEL
    $CASI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Tempest Therapeutics upgraded by H.C. Wainwright with a new price target

    H.C. Wainwright upgraded Tempest Therapeutics from Neutral to Buy and set a new price target of $11.00

    1/22/26 8:24:05 AM ET
    $TPST
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Fresenius Medical downgraded by Goldman

    Goldman downgraded Fresenius Medical from Buy to Neutral

    1/20/26 9:08:47 AM ET
    $FMS
    Misc Health and Biotechnology Services
    Health Care

    Johnson Rice initiated coverage on Hyliion

    Johnson Rice initiated coverage of Hyliion with a rating of Buy

    10/21/25 7:20:02 AM ET
    $HYLN
    Construction/Ag Equipment/Trucks
    Consumer Discretionary

    $AGIL
    $ATHX
    $BCEL
    $CASI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    ParaZero Secured an Order Valued at Over $650,000 From a Tier-1 International Drone Interception Company

    Kfar Saba, Israel, April 01, 2026 (GLOBE NEWSWIRE) -- ParaZero Technologies Ltd. (NASDAQ:PRZO) (the "company" or "ParaZero"), an aerospace defense company pioneering smart, autonomous solutions for the global manned and unmanned aerial systems (UAS) industry, today announced that it has signed a framework agreement with a Tier-1 international company who specializes in autonomous drone interception. Under the agreement, ParaZero will conduct a full integration of its DefendAir Net Pod into the client's new autonomous drone platform, ensuring seamless compatibility with the drone's configuration. In addition to the integration, the client will purchase a minimum of 2,000 customized Defend

    4/1/26 8:32:00 AM ET
    $PRZO
    Military/Government/Technical
    Industrials

    Tempest Reports Year End 2025 Financial Results and Provides Business Update

    Completed strategic acquisition of dual-targeting CAR-T assets from Factor Bioscience Inc. Named Matt Angel, Ph.D., Chief Executive Officer & President Announced positive interim data from the ongoing REDEEM-1 Phase 1/2a trial of TPST-2003 in patients with relapsed/refractory multiple myeloma (rrMM) BRISBANE, Calif., March 30, 2026 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (NASDAQ:TPST) ("Tempest"), a clinical-stage biotechnology company developing a pipeline of advanced CAR-T cell therapy product candidates to treat cancer, today reported financial results for the year ended December 31, 2025, and provided a corporate update. "2025 was a transformative year for Tempest as we stre

    3/30/26 9:00:00 AM ET
    $TPST
    Biotechnology: Pharmaceutical Preparations
    Health Care

    ParaZero Issues CEO Letter to Shareholders: Reports Strong Revenue Growth for Full Year 2025

    KFAR SABA, Israel, March 27, 2026 (GLOBE NEWSWIRE) -- ParaZero Technologies Ltd. (NASDAQ:PRZO) (the "company" or "ParaZero"), an aerospace defense company pioneering smart, autonomous solutions for the global manned and unmanned aerial systems (UAS) industry, today issued a Letter to Shareholders from Ariel Aron, Chief Executive Officer. Dear Shareholders and Partners, 2025 will be remembered as a transformative year and a significant strategic turning point for ParaZero. I am writing to you today as we stand at the threshold of a new era. ParaZero has successfully completed a fundamental transformation, evolving from a pioneer in drone safety components into a leader in multi-layered au

    3/27/26 7:00:00 AM ET
    $PRZO
    Military/Government/Technical
    Industrials

    $AGIL
    $ATHX
    $BCEL
    $CASI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Trojanowski Justin

    4 - Tempest Therapeutics, Inc. (0001544227) (Issuer)

    4/2/26 5:00:36 PM ET
    $TPST
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Maestas Nicholas

    4 - Tempest Therapeutics, Inc. (0001544227) (Issuer)

    4/2/26 5:00:35 PM ET
    $TPST
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Magnetar Financial Llc

    4 - Wheeler Real Estate Investment Trust, Inc. (0001527541) (Issuer)

    3/31/26 8:24:33 PM ET
    $WHLR
    Real Estate Investment Trusts
    Real Estate

    $AGIL
    $ATHX
    $BCEL
    $CASI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Freeland Richard Joseph bought $102,050 worth of shares (65,000 units at $1.57), increasing direct ownership by 41% to 222,798 units (SEC Form 4)

    4 - Hyliion Holdings Corp. (0001759631) (Issuer)

    8/21/25 5:28:06 PM ET
    $HYLN
    Construction/Ag Equipment/Trucks
    Consumer Discretionary

    Chief Accounting Officer. Standley Greg bought $5,650 worth of shares (5,000 units at $1.13), increasing direct ownership by 2% to 241,659 units (SEC Form 4)

    4 - Hyliion Holdings Corp. (0001759631) (Issuer)

    5/27/25 6:31:02 PM ET
    $HYLN
    Construction/Ag Equipment/Trucks
    Consumer Discretionary

    Chief Commercial Officer Ramasamy Govindaraj bought $22,600 worth of shares (20,000 units at $1.13), increasing direct ownership by 4% to 573,002 units (SEC Form 4)

    4 - Hyliion Holdings Corp. (0001759631) (Issuer)

    5/27/25 6:29:51 PM ET
    $HYLN
    Construction/Ag Equipment/Trucks
    Consumer Discretionary

    $AGIL
    $ATHX
    $BCEL
    $CASI
    Financials

    Live finance-specific insights

    View All

    Mobilicom Reports 2025 Year-End Financial Results

    A Mobilicom Tier-1 defense customer won a U.S. Department of War (DoW) Program of Record, indicating a potential production scale orders for the next 5 years  Cash and cash equivalents surge 120% to $19.1 million following $12.6 million in 2025 warrants exercise and equity raises With revenues up year-over-year at $3.4 million, monthly operating cash burn was cut by 41% to ~$159K — lowest in Company history — with zero-debt on balance sheet Launch of industry-first Secured Autonomy™ cybersecurity framework, multiple new design wins across Europe, Middle East and South Asia, and expanded U.S. Tier-1 drone production-scale orders drive multi-market momentum Webcast scheduled for 4:30 pm E

    3/23/26 4:06:00 PM ET
    $MOB
    Aerospace
    Industrials

    Mobilicom to Report Full Year 2025 Financial and Operating Results on March 23, 2026

    Palo Alto, California, March 16, 2026 (GLOBE NEWSWIRE) -- Mobilicom Limited (NASDAQ:MOB, MOBBW), MOBBW) ("Mobilicom" or the "Company"), a provider of cybersecurity and robust solutions for drones and robotics, today announced that it will issue a press release with its financial and operational results for the twelve months ended December 31, 2025 before the Nasdaq Stock Market opens on Monday, March 23, 2026. The Company will also discuss its results and other corporate developments, followed by a Q&A session, on a conference call at 4:30 p.m. EST the same day. Investors are invited to email questions to the Company in advance to: [email protected]. Conference call & webcast info: Monda

    3/16/26 8:00:00 AM ET
    $MOB
    Aerospace
    Industrials

    Fresenius Medical Care delivers 27% earnings growth in 2025 and reaches upper end of its financial outlook; margin within 2025 mid-term target band

    Strong organic revenue growth1 in 2025 of 8% driven by all operating segmentsDriven by an exceptional Q4, full year operating income2 growth of 27% reached top end of financial outlook, resulting in a significant margin step up to 11.3%Reported operating income grew by 31%, reported net income3 by 82%Earnings per share2 (EPS) grew by 44%, supported by the accelerated share buyback programDividend of EUR 1.49 (+3%) planned to be proposedFY 2026 outlook operating income is forecast to remain on a consistent level despite significant additional headwindsBAD HOMBURG, Germany, Feb. 24, 2026 /PRNewswire/ -- "Fresenius Medical Care closed a milestone year marked by outstanding profitability gains.

    2/24/26 7:00:00 AM ET
    $FMS
    Misc Health and Biotechnology Services
    Health Care

    $AGIL
    $ATHX
    $BCEL
    $CASI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Wheeler Real Estate Investment Trust Inc.

    SC 13D/A - Wheeler Real Estate Investment Trust, Inc. (0001527541) (Subject)

    12/9/24 5:54:19 PM ET
    $WHLR
    Real Estate Investment Trusts
    Real Estate

    Amendment: SEC Form SC 13G/A filed by Wheeler Real Estate Investment Trust Inc.

    SC 13G/A - Wheeler Real Estate Investment Trust, Inc. (0001527541) (Subject)

    12/5/24 5:28:41 PM ET
    $WHLR
    Real Estate Investment Trusts
    Real Estate

    Amendment: SEC Form SC 13G/A filed by Wheeler Real Estate Investment Trust Inc.

    SC 13G/A - Wheeler Real Estate Investment Trust, Inc. (0001527541) (Subject)

    11/14/24 6:36:47 PM ET
    $WHLR
    Real Estate Investment Trusts
    Real Estate

    $AGIL
    $ATHX
    $BCEL
    $CASI
    Leadership Updates

    Live Leadership Updates

    View All

    ParaZero Strengthens Global Sales Leadership with Appointment of Bat-Sheva Noy as VP

    Kfar Saba, Israel, March 04, 2026 (GLOBE NEWSWIRE) -- ParaZero Technologies Ltd. (NASDAQ:PRZO) (the "company" or "ParaZero"), an aerospace defense company pioneering smart, autonomous solutions for the global manned and unmanned aerial systems (UAS) industry, recently announced the appointment of Bat-Sheva Noy as its new Vice President of Global Sales. Ms. Noy brings more than 20 years of extensive commercial and leadership experience, with particular expertise in strategic planning, market access, and leading cross-functional teams. Most recently, from 2020 to 2025, she served as the Business Unit Lead for Rare Diseases at Pfizer Israel ((a subsidiary of Pfizer Inc., NYSE:PFE). In that

    3/4/26 8:32:00 AM ET
    $PFE
    $PRZO
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Military/Government/Technical
    Industrials

    Military UAV Sector Forecast to Surpass $40+ Billion as Modern Warfare Evolves

    NEW YORK, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Market News Updates News Commentary - Unmanned aerial vehicles (UAVs), commonly known as drones, have become a transformative technology in modern defense and military operations, reshaping strategies from reconnaissance to precision strike capabilities. Military drones offer armed forces enhanced situational awareness, reduced risk to personnel, and cost-efficient mission profiles across surveillance, target acquisition, logistics, and electronic warfare. As autonomous systems incorporating artificial intelligence and advanced sensor suites continue to mature, they are increasingly integral to networked battlefield operations and force multiplie

    2/19/26 8:30:00 AM ET
    $NOC
    $PRZO
    $UAVS
    Industrial Machinery/Components
    Industrials
    Military/Government/Technical
    Aerospace

    Fresenius Medical Care appoints Charles Hugh-Jones as Global Chief Medical Officer and member of the Management Board

    Effective January 1, 2026, Charles Hugh-Jones will join the Management Board as Global Chief Medical OfficerAs part of a planned transition Franklin W. Maddux will retire by year endBAD HOMBURG, Germany, Dec. 10, 2025 /PRNewswire/ -- The Supervisory Board of Fresenius Medical Care, the world's leading provider of products and services for individuals with renal disease, has appointed Charles Hugh-Jones, MD, FRCP (56) as a member of the Management Board, effective January 1, 2026. Mr. Hugh-Jones will serve as Global Chief Medical Officer. Mr. Hugh-Jones will succeed Franklin (F

    12/10/25 8:00:00 AM ET
    $FMS
    Misc Health and Biotechnology Services
    Health Care